Prosecutors allege Joel Rufus French used overseas call centers and altered recordings to make orthotic braces appear justified. DOJ also claims straw-owned DME suppliers helped funnel fraudulent reimbursements to Medicare and CHAMPVA.

The DOJ press release says the Medicare and CHAMPVA fraud case against Joel Rufus French depended on operational steps designed to manufacture “medical necessity.” Prosecutors allege French and co-conspirators used overseas telemarketing call centers to reach patients and to promote orthotic braces. DOJ further claims the scheme involved sham telemedicine—an arrangement prosecutors describe as used to create the appearance of legitimate evaluations and patient eligibility for reimbursable care. A key allegation in DOJ’s account is the manipulation of evidence. DOJ says French used call centers and altered recordings, which prosecutors characterize as part of the process for supporting fraudulent patient interactions and documentation. The government also alleges straw-owned durable medical equipment (DME) suppliers were part of the workflow, providing a way to submit claims through intermediaries rather than directly tying the scheme to a single entity. By combining deceptive outreach, purported remote medical processing, and falsified or modified supporting materials, prosecutors say the conspiracy enabled medically unnecessary claims to reach Medicare and VA-linked CHAMPVA. DOJ characterizes the approach as particularly harmful to older and disabled victims who may have relied on the legitimacy of remote medical instructions and the reimbursement system. French’s 196-month sentence reflects DOJ’s view that the conduct was both sophisticated and extensive, involving health care fraud and money laundering tied to large-scale improper payments.